biopharma dive - Robuta Search

https://www.biopharmadive.com/ Biotech and Pharma Industry News | BioPharma Dive BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development,... biotech and pharma industry news biopharma dive https://ibtimes.tradepub.com/free-offer/exploring-integrated-development-models-for-early-phase-biotech/w_thbs221?sr=hm&_t=hm Exploring Integrated Development Models for Early-Phase Biotech, Free BioPharma Dive's Studio by... Free Playbook to Exploring Integrated Development Models for Early-Phase Biotech This playbook examines how early-phase biotech companies operating under... integrated development early phase biopharma dive exploring models https://www.biopharmadive.com/news/foundayo-prescriptions-psychedelics-regeneron-trump-amgen-novo-bridgebio/818284/ Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics | BioPharma Dive Apr 24, 2026 - Lilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from that of oral Wegovy. Elsewhere, Regeneron inked a drug price deal and two... biopharma dive lilly shaky week fda https://www.biopharmadive.com/selfservice/event-listings/contact List your event | BioPharma Dive list your event biopharma dive Sponsored https://haremvilla.net/ Harem Villa - Free RPG Dating Sim for PC & Mobile Play Harem Villa, the addictive merge puzzle game where you restore a luxury villa and romance stunning characters. Free dating sim on PC & Mobile! https://www.biopharmadive.com/news/intellia-gene-editing-hereditary-angioedema-lonvo-z-results/818503/ Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder | BioPharma Dive The findings position Intellia to bring to market the first “in vivo” gene editing medicine, though the therapy’s commercial potential remains the source of... late stage biopharma dive crispr drug study https://www.biopharmadive.com/news/ai-pharma-scientist-drug-research-owkin/818280/ An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma? | BioPharma Dive A new tool is giving researchers a “data center full of genius Ph.D. students in their pocket.” for pharma biopharma dive tackle drug mean https://www.biopharmadive.com/news/vima-movement-disorder-dystonia-parkinsons-biotech-startup-financing/814337/ With $100M, Vima pursues an oral drug for movement disorders | BioPharma Dive Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or Parkinson's disease regain... movement disorders biopharma dive 100m oral drug https://www.biopharmadive.com/news/ucb-neurona-deal-acquisition-cell-therapy-epilepsy-biotech/817863/ UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B | BioPharma Dive The acquisition helps diversify UCB’s small molecule-centric arsenal of seizure treatments with a potentially one-off therapy in early testing for a... cell therapy biopharma dive ucb betting seizure https://www.biopharmadive.com/topic/pharma/ Pharma News | BioPharma Dive The latest pharma news for biotech and biopharmaceutical professionals pharma news biopharma dive https://www.biopharmadive.com/news/sanofi-earnings-q1-2026-dupixent-vaccines-immunology/818283/ Sanofi posts upbeat sales as R&D pressure builds | BioPharma Dive A string of research setbacks have left the pharmaceutical giant at a crossroads just as a new CEO is set to take over. But positive first-quarter earnings... as r biopharma dive sanofi posts upbeat https://www.biopharmadive.com/advertise/ BioPharma Dive Advertising Page biopharma dive advertising page https://www.biopharmadive.com/news/nektar-rezpegaldesleukin-alopecia-areata-extension-results/817926/ Nektar surges again as alopecia drug shows new promise in extension study | BioPharma Dive Patients who'd seen substantial hair regrowth in the first part of Nektar’s trial had a "deepening" treatment response, extending a comeback bid that’s caused... biopharma dive nektar alopecia drug shows https://www.biopharmadive.com/news/biotech-pharma-clinical-trials-watch-2026/808255/ 10 clinical trials to watch in the first half of 2026 | BioPharma Dive clinical trials to watch the first biopharma dive half https://www.biopharmadive.com/topic/gene-therapy/ Gene Therapy News | BioPharma Dive The latest gene therapy news for biotech and biopharmaceutical professionals gene therapy biopharma dive news Sponsored https://cams.com/ Cams.com - Free Sex Cams, Live Sex Chat 24/7 Live sex cams, watch and go one on one with your favorite model at Cams.com 🔥 Join free. https://www.biopharmadive.com/editors/ Editorial Team | BioPharma Dive editorial team biopharma dive https://www.biopharmadive.com/what-we-are-reading/ What We're Reading | BioPharma Dive biopharma dive reading https://resources.industrydive.com/Structured-Intelligence-How-AI-Is-Transforming-High-Stakes-RD-Decisions Structured Intelligence: How AI Is Transforming High-Stakes R&D Decisions | BioPharma Dive high stakes biopharma dive structured intelligence ai https://www.biopharmadive.com/news/moderna-mrna-bird-flu-vaccine-trial-cepi-hhs/818172/ Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial | BioPharma Dive A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test... bird flu biopharma dive moderna losing us https://www.biopharmadive.com/news/regeneron-fda-otarmeni-hearing-loss-gene-therapy-voucher/818345/ FDA approves Regeneron’s hearing loss gene therapy | BioPharma Dive Otarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA’s “national priority” voucher program... hearing loss gene therapy biopharma dive fda https://www.biopharmadive.com/news/lilly-kelonia-acquire-in-vivo-cell-therapy-multiple-myeloma/817953/ Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout | BioPharma Dive Worth up to $7 billion, Lilly’s second recent acquisition of a company in the space is centered around a cell therapy that’s currently in early-stage testing... cell therapy biopharma dive lilly boosts capabilities https://ibtimes.tradepub.com/free-offer/making-medical-affairs-content-more-accessible-for-patients/w_ream17?sr=hm&_t=hm: Making Medical Affairs Content More Accessible for Patients, Free BioPharma Dive's Studio by... Free Playbook to Making Medical Affairs Content More Accessible for Patients This playbook explores how medical communications can be more patient-centric by... medical affairs for patients biopharma dive making content https://www.biopharmadive.com/news/merck-welireg-1l-renal-cell-carcinoma-study-results/818093/ Merck’s fast-ascending kidney cancer drug hits a setback | BioPharma Dive Welireg’s failure in first-line kidney cancer removes a blockbuster opportunity and could leave an opening for a rival drug from Arcus Biosciences, analysts... kidney cancer biopharma dive fast ascending drug Sponsored https://sexmessenger.com/ Sex Messenger – Free Dating & Hookups Made Easy! It's never been this easy to meet hot girls online. SexMessenger.com dating software will forever change the way you hookup with beautiful girls on the web. https://www.biopharmadive.com/news/pfizer-tafamidis-vyndamax-settlement-generic-patents-ttr-cardiomyopathy/818705/ Pfizer deals extend patent life for a top-selling rare disease drug | BioPharma Dive Settlements delaying the arrival of generic versions of tafamidis will protect billions in Pfizer revenue and have implications for others, including BridgeBio... for a top selling rare disease biopharma dive pfizer https://www.biopharmadive.com/news/trump-psychedelics-executive-order-mental-health-neuroscience-psychiatry-biotech/818021/ Trump executive order lifts psychedelics biotechs | BioPharma Dive Meant to speed research and access to psychedelics for mental health conditions, the order is the latest in a series of developments that, to Wall Street, make... executive order biopharma dive trump lifts psychedelics https://www.biopharmadive.com/news/serif-flagship-biotech-startup-modified-dna-mrna/817719/ Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine | BioPharma Dive The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy. a new biopharma dive serif latest biotech https://www.biopharmadive.com/news/aacr-2026-revolution-zoldonrasib-merck-vegf-nuvalent-nuvation/817916/ AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle | BioPharma Dive Featured at this year’s meeting on early cancer research were results from an immunotherapy Merck acquired in 2024 and several targeted medicines for lung... aacr 2026 lung cancer biopharma dive next prospect https://www.biopharmadive.com/news/coultreon-biotech-startup-galapagos-immune-drug-financing/818575/ Coultreon banks $125M to support testing of former Galapagos immune drug | BioPharma Dive Backed by Novo Holdings, Regeneron’s venture arm and several others, the biotech believes an oral drug licensed from Galapagos might hold potential treating... biopharma dive banks support testing former https://thehackernews.tradepub.com/free-offer/making-medical-affairs-content-more-accessible-for-patients/w_ream17?sr=hm&_t=hm: Making Medical Affairs Content More Accessible for Patients, Free BioPharma Dive's Studio by... Free Playbook to Making Medical Affairs Content More Accessible for Patients This playbook explores how medical communications can be more patient-centric by... medical affairs for patients biopharma dive making content https://www.biopharmadive.com/news/robert-f-kennedy-jr-rfk-jr-defends-hhs-tenure-proposed-budget-cut/817975/ RFK Jr. defends HHS tenure, 12% proposed budget cut | BioPharma Dive Republicans largely praised the HHS secretary’s track record during a marathon of House hearings last week, but some raised concerns about proposed budget cuts... rfk jr proposed budget biopharma dive hhs tenure https://www.biopharmadive.com/library/ Whitepapers, webinars, and videos | BioPharma Dive Whitepapers, webinars, videos, PDF downloads and other resources about the biotech and biopharmaceutical industry webinars and videos biopharma dive whitepapers https://www.biopharmadive.com/topic/fda/ FDA News | BioPharma Dive The latest FDA news for biotech and biopharmaceutical professionals biopharma dive fda news https://www.biopharmadive.com/signup/?signup_location=header BioPharma Dive Newsletter Sign Up Get the free biotech newsletter trusted by industry leaders. BioPharma Dive delivers the biotech and pharma news affecting businesses today. newsletter sign up biopharma dive https://www.biopharmadive.com/topic/biotech/ Biotech News | BioPharma Dive The latest biotech news for biopharmaceutical professionals biotech news biopharma dive https://www.biopharmadive.com/news/veradermics-oral-minoxidil-baldness-hair-loss-study-results/818529/ Veradermics soars on positive data for baldness treatment | BioPharma Dive The results could support the first approval in decades for an oral medicine that can treat male pattern baldness, though the therapy will face competition... biopharma dive soars positive data baldness https://resources.industrydive.com/Scaling-Microbial-Early-Decisions-into-Commercial-Readiness Scaling Microbial Early Decisions into Commercial Readiness | BioPharma Dive This webinar explores critical scale-up principles observed across high-performing microbial programs, from early decisions to commercial readiness. biopharma dive scaling microbial early decisions https://www.biopharmadive.com/?page=2 Biotech and Pharma Industry News | BioPharma Dive BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development,... biotech and pharma industry news biopharma dive https://www.biopharmadive.com/news/biotech-ipo-performance-tracker/587604/ Biotech IPOs are the industry’s lifeblood. Track how they’re performing. | BioPharma Dive biopharma dive biotech ipos track performing https://www.biopharmadive.com/news/fda-peptides-rfk-advisory-committee-restrictions/817685/ FDA moves toward easing restrictions on certain peptides | BioPharma Dive The agency’s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F. Kennedy Jr. told podcaster Joe Rogan he’s a “big... biopharma dive fda moves easing restrictions https://www.biopharmadive.com/news/us-uk-drug-price-deal-pharmaceuticals-tariffs/806662/ UK agrees to boost drug prices to dodge US pharma tariffs | BioPharma Dive A deal announced Monday will see the U.K. temporarily sidestep levies on Britain-originated drugs by loosening rules that restrain prices for new medicines. drug prices biopharma dive uk agrees boost https://www.biopharmadive.com/about/ About Us | BioPharma Dive BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping the biotech and biopharmaceutical industry. biopharma dive us https://thehackernews.tradepub.com/free-offer/exploring-integrated-development-models-for-early-phase-biotech/w_thbs221?sr=hm&_t=hm: Exploring Integrated Development Models for Early-Phase Biotech, Free BioPharma Dive's Studio by... Free Playbook to Exploring Integrated Development Models for Early-Phase Biotech This playbook examines how early-phase biotech companies operating under... integrated development early phase biopharma dive exploring models https://www.biopharmadive.com/contact/ Contact | BioPharma Dive biopharma dive https://www.biopharmadive.com/news/tortugas-biotech-startup-jonas-robichaud-hansoh-eisai/818076/ Tortugas debuts with $106M and brain drugs from Hansoh, Eisai | BioPharma Dive Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical... biopharma dive tortugas debuts brain drugs https://www.biopharmadive.com/news/bioage-nlrp3-drug-results-inflammation-cardiovascular-risk-obesity/818054/ BioAge says early data suggest ‘best-in-class’ potential for inflammation drug | BioPharma Dive The company has rallied from an earlier setback in obesity thanks to early progress for a drug targeting “NLRP3,” an inflammasome linked to a variety of health... early data biopharma dive says suggest potential https://www.biopharmadive.com/news/lilly-ajax-deal-acquire-jak-myelofibrosis-drug/818523/ Lilly to buy startup Ajax in bid for a better JAK drug | BioPharma Dive Worth up to $2.3 billion overall, the deal hands Lilly a drug designed to address the weaknesses of a class of medicines used to treat myelofibrosis and other... for a biopharma dive lilly buy startup https://resources.industrydive.com/top-ways-that-ai-will-change-life-sciences Top Ways that AI Will Change Life Sciences | BioPharma Dive Hear about AI’s potential to revolutionize Life Sciences. We’ll discuss important and relevant ways AI can transform the industry such as intelligent clinical... life sciences biopharma dive top ways ai https://thehackernews.tradepub.com/free-offer/exploring-integrated-development-models-for-early-phase-biotech/w_thbs221?sr=hm&_t=hm Exploring Integrated Development Models for Early-Phase Biotech, Free BioPharma Dive's Studio by... Free Playbook to Exploring Integrated Development Models for Early-Phase Biotech This playbook examines how early-phase biotech companies operating under... integrated development early phase biopharma dive exploring models https://www.biopharmadive.com/news/biotech-startups-commercial-drugs-bridgebio-madrigal-kailera-argenx/817992/ Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead. | BioPharma Dive Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more... m a biopharma dive biotech investors gamble Sponsored https://chaturbate.com/ Chaturbate: Free Adult Webcams, Live Sex, Free Sex Chat, Exhibitionist and Pornstar Free Cams https://www.biopharmadive.com/news/revolution-aacr-2026-daraxonrasib-pancreatic-cancer-results/818173/ Revolution drug shows promise in early pancreatic cancer | BioPharma Dive The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales. pancreatic cancer biopharma dive revolution drug shows Sponsored https://www.slayed.com/ SLAYED: High-End 4K Videos Featuring Beautiful Women Together Watch unforgettable connections between stunning women in premium cinematic scenes. SLAYED delivers sensual all-female experiences and breathtaking 4K visuals... https://www.biopharmadive.com/press-release/ Biotech and Pharma Press Releases | BioPharma Dive biotech and pharma press releases biopharma dive https://www.biopharmadive.com/news/sanofis-tolebrutinib-cenrifki-ms-europe-recommend-approval/818414/ Sanofi MS drug rejected in US gets an endorsement in Europe | BioPharma Dive Tolebrutinib, which the FDA recently turned back due to safety concerns, received a positive recommendation that positions the therapy for its first regulatory... biopharma dive sanofi ms drug rejected https://www.biopharmadive.com/news/survodutide-obesity-drug-results-boehringer-ingelheim-zealand/818664/ Boehringer dual-acting obesity shot hits mark in Phase 3 trial | BioPharma Dive Survodutide spurred weight loss Wall Street analysts referred to as “Wegovy-like,” and showed signs it might help preserve muscle mass as well. phase 3 biopharma dive dual acting obesity Sponsored https://www.sexyfans.app/ Sexyfans.app - Only Fans of Dating Apps Welcome The Only Dating App for Fans to Meetup with Local Content Creators.. https://www.biopharmadive.com/press-release/get-started/ Press Release Distribution Service | BioPharma Dive press release distribution biopharma dive service https://thehackernews.tradepub.com/free-offer/making-medical-affairs-content-more-accessible-for-patients/w_ream17?sr=hm&_t=hm Making Medical Affairs Content More Accessible for Patients, Free BioPharma Dive's Studio by... Free Playbook to Making Medical Affairs Content More Accessible for Patients This playbook explores how medical communications can be more patient-centric by... medical affairs for patients biopharma dive making content Sponsored https://darlink.ai/ DarLink AI: Free AI Girlfriend Generator | Chat, Photos & Video Create your ideal AI Girlfriend with DarLink AI. Customize her look and personality, chat naturally, and enjoy personalized photos, videos, and voice for a... https://ibtimes.tradepub.com/free-offer/making-medical-affairs-content-more-accessible-for-patients/w_ream17?sr=hm&_t=hm Making Medical Affairs Content More Accessible for Patients, Free BioPharma Dive's Studio by... Free Playbook to Making Medical Affairs Content More Accessible for Patients This playbook explores how medical communications can be more patient-centric by... medical affairs for patients biopharma dive making content https://ibtimes.tradepub.com/free-offer/exploring-integrated-development-models-for-early-phase-biotech/w_thbs221?sr=hm&_t=hm: Exploring Integrated Development Models for Early-Phase Biotech, Free BioPharma Dive's Studio by... Free Playbook to Exploring Integrated Development Models for Early-Phase Biotech This playbook examines how early-phase biotech companies operating under... integrated development early phase biopharma dive exploring models https://www.biopharmadive.com/newsletter@ittnewsletter.com Page not found | BioPharma Dive page not found biopharma dive https://www.biopharmadive.com/topic/drug-pricing/ Drug Pricing News | BioPharma Dive The latest drug pricing news for biotech and biopharmaceutical professionals drug pricing biopharma dive news https://resources.industrydive.com/Companion-Diagnostic-Spoiler-Alert-Start-at-the-End-Before-You-Begin Companion Diagnostic Spoiler Alert: Start at the End Before You Begin | BioPharma Dive In this webinar, attendees will gain insights into how they can evaluate potential companion diagnostic partners not just for their development skills but for... before you begin the end biopharma dive companion diagnostic https://www.biopharmadive.com/events/ Upcoming events | BioPharma Dive upcoming events biopharma dive https://www.biopharmadive.com/signup/?signup_location=footer-list&signup_path=/ BioPharma Dive Newsletter Sign Up Get the free biotech newsletter trusted by industry leaders. BioPharma Dive delivers the biotech and pharma news affecting businesses today. newsletter sign up biopharma dive https://www.biopharmadive.com/topic/clinical-trials/ Clinical Trial News | BioPharma Dive The latest clinical trial news for biotech and biopharmaceutical professionals clinical trial biopharma dive news https://www.biopharmadive.com/news/kailera-ipo-price-obesity-drugs-hengrui-ron-renaud/817463/ Kailera nets $625M in one of biotech’s biggest-ever IPOs | BioPharma Dive The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to support a portfolio of medicines... one of biopharma dive nets biggest ever https://www.biopharmadive.com/selfservice/article-licensing/submit/ License our articles | BioPharma Dive our articles biopharma dive license https://www.biopharmadive.com/news/roche-q1-2026-earnings-giredestrant-obesity-drugs/818300/ Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs | BioPharma Dive On a conference call, executives claimed that a closely watched breast cancer pill and portfolio of weight loss medicines could bank more than $9 billion... biopharma dive roche facing threats puts https://www.biopharmadive.com/topic/deals/ Deals | BioPharma Dive biopharma dive deals https://www.biopharmadive.com/news/biotech-pharma-deals-merger-acquisitions-tracker/604262/ Biotech M&A is accelerating. Track the deals that are happening here. | BioPharma Dive m a biopharma dive biotech track deals https://www.biopharmadive.com/news/oruka-plaque-psoriasis-drug-study-results/818527/ Oruka surges as long-acting psoriasis drug shows early promise | BioPharma Dive A therapy that works similarly to AbbVie’s blockbuster Skyrizi appeared more potent in a mid-stage trial and has the potential to be dosed less frequently. biopharma dive long acting psoriasis drug https://www.biopharmadive.com/news/merck-google-idvynso-roche-fenebrutinib-arcus-gilead-ray/817987/ Merck adds to pharma’s AI push; Roche details MS drug results | BioPharma Dive Merck is making a $1 billion investment in a deal with Google Cloud. Elsewhere, Roche pitched its case for a closely watched multiple sclerosis pill and Arcus... biopharma dive merck adds ai push https://www.biopharmadive.com/deep-dive/ Deep Dive | BioPharma Dive deep dive biopharma https://ibtimes.tradepub.com/free-offer/how-middlesex-county-in-new-jersey-boosts-biopharma-growth/w_midd06?sr=hm&_t=hm How Middlesex County in New Jersey Boosts Biopharma Growth, Free BioPharma Dive's Studio by Informa... Free Infographic to How Middlesex County in New Jersey Boosts Biopharma Growth This infographic explores how Middlesex County in New Jersey offers an ecosystem... middlesex county new jersey boosts biopharma growth https://thehackernews.tradepub.com/free-offer/how-middlesex-county-in-new-jersey-boosts-biopharma-growth/w_midd06?sr=hm&_t=hm: How Middlesex County in New Jersey Boosts Biopharma Growth, Free BioPharma Dive's Studio by Informa... Free Infographic to How Middlesex County in New Jersey Boosts Biopharma Growth This infographic explores how Middlesex County in New Jersey offers an ecosystem... middlesex county new jersey boosts biopharma growth Sponsored https://www.luvr.ai/ Luvr AI - Your AI girlfriend | AI Girlfriend Chat | AI Girlfriend Free Fall in love with your personal AI Girlfriend on Luvr AI! Enjoy AI Girlfriend Chat and free features with fully uncensored character roleplay